{"organizations": [], "uuid": "303cd5a928546cfe51dc9917715dece85a9271ca", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180214.html", "section_title": "Archive News &amp; Video for Wednesday, 14 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sumitomo-dainippon-pharma-files-pa/brief-sumitomo-dainippon-pharma-files-patent-infringement-lawsuits-regarding-latuda-in-u-s-idUSL4N1Q42FZ", "country": "US", "domain_rank": 408, "title": "BRIEF-Sumitomo Dainippon Pharma files patent infringement lawsuits regarding lATUDA® in U.S.", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-02-14T13:21:00.000+02:00", "replies_count": 0, "uuid": "303cd5a928546cfe51dc9917715dece85a9271ca"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sumitomo-dainippon-pharma-files-pa/brief-sumitomo-dainippon-pharma-files-patent-infringement-lawsuits-regarding-latuda-in-u-s-idUSL4N1Q42FZ", "ord_in_thread": 0, "title": "BRIEF-Sumitomo Dainippon Pharma files patent infringement lawsuits regarding lATUDA® in U.S.", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "delaware", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sumitomo dainippon pharma co ltd", "sentiment": "negative"}, {"name": "dainippon pharma", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "u.s. eastern time", "sentiment": "none"}, {"name": "u.s. district court", "sentiment": "none"}, {"name": "amneal pharmaceuticals llc", "sentiment": "none"}, {"name": "u.s. district court for the district of new jersey", "sentiment": "none"}, {"name": "latuda", "sentiment": "none"}, {"name": "sunovion pharmaceuticals inc.", "sentiment": "none"}, {"name": "emcure pharmaceuticals ltd.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Sumitomo Dainippon Pharma Co Ltd\n* Says it filed patent infringement lawsuits jointly with its U.S. subsidiary, Sunovion Pharmaceuticals Inc. on February 13(U.S. Eastern Time) in the U.S. District Court for the District of New Jersey against Emcure Pharmaceuticals Ltd. and in the U.S. District Court for the District of Delaware against Amneal Pharmaceuticals LLC regarding their submissions of Abbreviated New Drug Applications for generic copies of LATUDA®(lurasidone HCl tablets)\nSource text in Japanese: goo.gl/ngtWJM\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/ngtWJM"], "published": "2018-02-14T13:21:00.000+02:00", "crawled": "2018-02-15T20:40:40.008+02:00", "highlightTitle": ""}